Stay updated on Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial
Sign up to get notified when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.

Latest updates to the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page
- Check4 days agoChange DetectedThere are no recorded textual changes for this page; the study details, eligibility, and outcomes appear unchanged.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page displays a new revision version (v3.6.5) for the study record, indicating a metadata update to the document. This update reflects a newer QC/content revision rather than a substantive change to trial details.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a small backend or CMS update without changing the study information shown to users.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page revision tag was updated to v3.6.3, reflecting a new revision of the study page. This does not modify the study details visible to users.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry v3.6.2 was added to the page's revision history, and the prior entry v3.6.0 was removed.SummaryDifference0.1%

- Check77 days agoChange DetectedThe study page adds a recruitment status note indicating that recruitment has ended and introduces new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the page revision to v3.6.0 and adjusting the Intervention/Treatment header formatting.SummaryDifference0.5%

Stay in the know with updates to Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.